Anat Loewenstein

Anat Loewenstein, MD, MHA, is a professor and director of the Department of Ophthalmology, Vice Dean of the Faculty of Medicine, and Sidney Fox Chair of Ophthalmology at Tel Aviv University. She is also Chairman of Ophthalmology at Sourasky Medical Center in Tel Aviv and President of the Israeli Ophthalmological Society.

Disclosures: Anat Loewenstein is a consultant to to Allergan, Bayer Healthcare, Beyeonics, Forsightlabs, NotalVision,Novartis, Roche, Syneos, Xbrane, Nanoretina, Ocuterra, Ripple Therapeutics, Annexon, MJHEvents, Iveric Bio, Biogen, Johnson & Johnson, Ocuphire Pharma, and Iqvia.

Content by Anat Loewenstein:

Subspecialties Retina

We Need a Multipronged Strategy for nAMD

09/20/2023 | Anat Loewenstein | 7 min read

Addressing the unmet visual acuity needs of neovascular AMD patients

Business & Profession Professional Development

Our Time to Shine

09/21/2021 | Anat Loewenstein

My message to all existing and future Power List champions

Subspecialties Diabetes

Shifting to a Systemic Approach

10/18/2019 | Anat Loewenstein

What does the future hold for the management – and treatment – of diabetic eye disease?

Subspecialties Retina

Joining Forces for Diabetes

04/29/2019 | Anat Loewenstein

Diabetic patients would be better served by coordinated care plan – and retina specialists must play their part

Subspecialties Retina

Consider the Alternative

01/11/2017 | Anat Loewenstein

When it comes to treating retinal disease, VEGF isn’t the only game in town.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

Unlimited access to ALL articles
News, interviews & opinions from leading industry experts
Receive print (and PDF) copies of The Ophthalmologist magazine

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: